These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25177566)

  • 41. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
    Clement M; Shehu E; Chandler T
    Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation of concurrent red blood cell and platelet collection by apheresis in a university haemapheresis unit.
    Moog R
    Transfus Med; 2004 Apr; 14(2):145-50. PubMed ID: 15113378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of donor-deferral pattern in a voluntary blood donor population.
    Chaudhary RK; Gupta D; Gupta RK
    Transfus Med; 1995 Sep; 5(3):209-12. PubMed ID: 8593526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudothrombocytopenia in plateletpheresis donors.
    Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
    Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Why the majority of on-site repeat donor deferrals are completely unwarranted….
    Janssen MP
    Transfusion; 2022 Oct; 62(10):2068-2075. PubMed ID: 36053780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insight into donor deferral pattern based on peripheral blood counts: An experience from South Pakistan.
    Sultan S; Irfan SM; Baig MA; Usman SM; Shirazi UA
    Asian J Transfus Sci; 2017; 11(2):151-155. PubMed ID: 28970684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
    Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
    J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact Analysis of the National Guidelines for Blood Donor Selection in India: A Single Center Study.
    Agnihotri N; Chaturvedi YM; Agnihotri A
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):726-730. PubMed ID: 31741628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of COVID-19 on blood donor deferral patterns during the COVID-19 pandemic: A retrospective analysis.
    Routray SS; Ray GK; Prakash S; Sahu A; Naik A; Mukherjee S
    Vox Sang; 2022 May; 117(5):656-663. PubMed ID: 35114023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The significance of evalution of haematocrit in plateletpheresis donors.
    Mane VB; Jagtap PE; Nagane NS; Dhonde SP; Belwalkar GJ; Mane VP
    J Clin Diagn Res; 2015 Apr; 9(4):BC06-7. PubMed ID: 26023547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do deferred donors continue their donations? A large-scale register study on whole blood donor return in the Netherlands.
    Spekman MLC; van Tilburg TG; Merz EM
    Transfusion; 2019 Dec; 59(12):3657-3665. PubMed ID: 31621923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Profile of blood donors and reasons for deferral in coastal South India.
    Unnikrishnan B; Rao P; Kumar N; Ganti S; Prasad R; Amarnath A; Reshmi B; Kaur V; Kesharwani P; Seetha M; Nautiyal A; Goel P; Aggarwal P
    Australas Med J; 2011; 4(7):379-85. PubMed ID: 23393523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of blood donor deferral characteristics in Delhi, India.
    Bahadur S; Jain S; Goel RK; Pahuja S; Jain M
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):1087-91. PubMed ID: 19842393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. REASONS FOR DEFERRAL IN DEFERRED VOLUNTARY BLOOD DONORS IN EASTERN CROATIA.
    Cipek V; Ferenac Kiš M; Ratić D; Piškorjanac S; Samardžija M; Kralik K; Samardžija M
    Acta Clin Croat; 2023 Apr; 62(1):93-105. PubMed ID: 38304378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India.
    Sahoo D; Noushad S; Basavarajegowda A; Toora E
    Asian J Transfus Sci; 2023; 17(1):34-40. PubMed ID: 37188018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should Kiribati continue to aim for 100% voluntary non-remunerated blood donation as recommended by the WHO?
    Tauma G; Harries AD; Merilles OE; Tekoaua R; Teriboriki B
    Public Health Action; 2016 Dec; 6(4):261-266. PubMed ID: 28123965
    [No Abstract]   [Full Text] [Related]  

  • 59. Whole blood donor deferral rate and characteristics of the Turkish population.
    Arslan O
    Transfus Med; 2007 Oct; 17(5):379-83. PubMed ID: 17725552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.